26 Oct AAO 2022
In collaboration with the American Society of Retinal Specialists, the American Academy of Ophthalmology held a special debate session on October 3, 2022 during its annual meeting in Chicago, where several topics were discussed. Dr. Sebag was invited to speak about his experience performing limited vitrectomy for vitreous floaters that disturb vision, called Vision Degrading Myodesopsia. Previously dismissed as just a nuisance and not a true disease, vitreous floaters are increasingly appreciated as a cause for vision loss, primarily the degradation in contrast sensitivity, Dr. Sebag argued. He went on to describe that limited vitrectomy is a highly successful procedure that is performed in 10 – 15 minutes under local anesthesia in an ambulatory surgery center. Technologic advances in surgical instrumentation and modifications in surgical technique have decreased patient discomfort, improved the safety profile, and shortened healing time, making this an attractive option for patients suffering from vision degrading myodesopsia. In his lecture, Dr. Sebag shared that several studies have confirmed a very low risk profile and documented significant improvements in vision and patient quality-of-life.
The 5-minute lecture presentation can be viewed at: https://www.dropbox.com/s/kkoy11idbq2a8j9/2022-10-07%2010-58-41.mkv?dl=0